Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ketamine’s effect on inflammation and kynurenine pathway in depression: A systematic review
Emma I Kopra, Valeria Mondelli, Carmine M. Pariante, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 8, pp. 934-945
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

The menace of obesity to depression and anxiety prevalence
Stephanie Fulton, Léa Décarie-Spain, Xavier Fioramonti, et al.
Trends in Endocrinology and Metabolism (2021) Vol. 33, Iss. 1, pp. 18-35
Open Access | Times Cited: 250
Tryptophan Metabolism in Depression: A Narrative Review with a Focus on Serotonin and Kynurenine Pathways
Ana Salomé Correia, Nuno Vale
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8493-8493
Open Access | Times Cited: 172
Role of Inflammatory Mechanisms in Major Depressive Disorder: From Etiology to Potential Pharmacological Targets
Bruna R. Kouba, Laura A. Borba, Pedro Borges de Souza, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 423-423
Open Access | Times Cited: 65
Neurobiology and systems biology of stress resilience
Raffaël Kalisch, Scott J. Russo, Marianne B. Müller
Physiological Reviews (2024) Vol. 104, Iss. 3, pp. 1205-1263
Open Access | Times Cited: 25
Recent Advances in the Mechanisms of Postoperative Neurocognitive Dysfunction: A Narrative Review
Tingting Wang, Xin Huang, Shujun Sun, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 115-115
Open Access | Times Cited: 2
Targeting neuroinflammation by polyphenols: A promising therapeutic approach against inflammation-associated depression
Mohammed Abu Tayab, Mohammad Nazmul Islam, Kazi Ashfak Ahmed Chowdhury, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112668-112668
Open Access | Times Cited: 62
Antidepressant mechanisms of ketamine: a review of actions with relevance to treatment-resistance and neuroprogression
August P. M. Lullau, E. Haga, Eivind Haga Ronold, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 38
Major depressive disorder as a neuro-immune disorder: Origin, mechanisms, and therapeutic opportunities
Gislaine Z. Réus, Luana M. Manosso, João Quevedo, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 155, pp. 105425-105425
Closed Access | Times Cited: 35
Neuroprotective effects of probiotics on anxiety- and depression-like disorders in stressed mice by modulating tryptophan metabolism and the gut microbiota
Longgang Jia, Ling Xiao, Yao Fu, et al.
Food & Function (2024) Vol. 15, Iss. 6, pp. 2895-2905
Closed Access | Times Cited: 12
Effect of esketamine on postoperative analgesia and postoperative delirium in elderly patients undergoing gastrointestinal surgery
Jing Liu, Tingting Wang, Song Jian, et al.
BMC Anesthesiology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Ketamine’s mechanism of action with an emphasis on neuroimmune regulation: can the complement system complement ketamine’s antidepressant effects?
Brandi Quintanilla, Carlos A. Zarate, Anilkumar Pillai
Molecular Psychiatry (2024) Vol. 29, Iss. 9, pp. 2849-2858
Closed Access | Times Cited: 8
Pain and Perception: Exploring Psychedelics as Novel Therapeutic Agents in Chronic Pain Management
Natalie Strand, Madeline Whitney, Brooks Johnson, et al.
Current Pain and Headache Reports (2025) Vol. 29, Iss. 1
Closed Access | Times Cited: 1
Connexin 43: An Interface Connecting Neuroinflammation to Depression
Hong Jiang, Yi Zhang, Zhen‐Zhen Wang, et al.
Molecules (2023) Vol. 28, Iss. 4, pp. 1820-1820
Open Access | Times Cited: 19
A unified model of the biology of peripartum depression
Gal Sahaf Levin, Tsachi Ein‐Dor
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency
Naghmeh Nikkheslat
Brain Behavior & Immunity - Health (2021) Vol. 18, pp. 100383-100383
Open Access | Times Cited: 38
The role of immunomodulators in treatment-resistant depression: case studies
Charles W. Beckett, Maria Victoria Niklison-Chirou
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 25
Neuroinflammation and neuroprogression in depression: Effects of alternative drug treatments
Brandon Richardson, Andrew J. Macpherson, Francis Rodriguez Bambico
Brain Behavior & Immunity - Health (2022) Vol. 26, pp. 100554-100554
Open Access | Times Cited: 24
Kynurenine pathway of tryptophan metabolism in pathophysiology and therapy of major depressive disorder
Abdulla A.‐B. Badawy, Shazia Dawood, Samina Bano
World Journal of Psychiatry (2023) Vol. 13, Iss. 4, pp. 141-148
Open Access | Times Cited: 15
Navigating the Neuroimmunomodulation Frontier: Pioneering Approaches and Promising Horizons—A Comprehensive Review
Antea Kršek, Leona Ostojić, Dorotea Zivalj, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9695-9695
Open Access | Times Cited: 5
Associations of pro-inflammatory factors and IL-10 levels with degree of suicide risk in adolescents with depression
Wenyuan Liu, Hongyu Zheng, Xin-Jian Wen, et al.
Frontiers in Psychiatry (2025) Vol. 15
Open Access
UPF 648, a Selective KMO Inhibitor, Attenuates Psychomotor and Cognitive Impairment in Chronic Kidney Disease
Aparajita Ghosh, Neeraja Rayanki, A. Joshi, et al.
ACS Chemical Neuroscience (2025) Vol. 16, Iss. 5, pp. 908-919
Closed Access
Emerging Viral Infections (ZIKV, SARS‐CoV‐2, and MPXV) and Depression: Ketamine and (S, R)‐Ketamine as Promising Antidepressants
Qianqian Cao, Ning Zhang, C. Leng, et al.
Reviews in Medical Virology (2025) Vol. 35, Iss. 3
Closed Access
High baseline plasma anthranilic acid predicts remission upon acute-series ketamine infusion for treatment-resistant depression
Stephen Murata, Zachary Madaj, Colt Capan, et al.
Biological Psychiatry Global Open Science (2025), pp. 100503-100503
Open Access
Intrinsic Connectivity Networks of Glutamate-Mediated Antidepressant Response: A Neuroimaging Review
Ilya Demchenko, Vanessa K. Tassone, Sidney H. Kennedy, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 21
Inflammation and serotonin deficiency in major depressive disorder: molecular docking of antidepressant and anti-inflammatory drugs to tryptophan and indoleamine 2,3-dioxygenases
Shazia Dawood, Samina Bano, Abdulla A.‐B. Badawy
Bioscience Reports (2022) Vol. 42, Iss. 5
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top